Research - Fremont, California, United States
ProbiusDx is an emerging venture-backed life science company developing next generation biochemical analysis solutions that combine quantum sensing and AI. Our technology yields a high-fidelity digital representation of the biochemistry of health for more detailed and predictive insights. With a vision to decentralize and dematerialize clinical diagnostics for personalized health monitoring, ProbiusDx has developed a bioanalytical platform that brings the unique integration of multiple scales of biological information to simultaneously identify and quantify small molecules, large molecules, single cell organisms and their interactions in any background matrix. Using quantum bio-electrochemistry, our multiscale phenotyping platform increases the amount of accessible information by a factor x1000 and can assay in the background matrix directly, without sample preparation and in limited sample volumes. Short term, it enables broad-spectrum and efficient longitudinal studies for pre-clinical therapeutic discovery and validation. Longer term, it will revolutionize healthcare by enabling individuals to monitor their biochemistry as a personalized baseline and close the loop between the patient, their doctor and their care provider digitally and in real time. We call this Diagnostics-as-a-Service (DaaS).
Outlook
DNS Made Easy
Rackspace MailGun
Google Cloud Hosting
Microsoft Office 365
Lever